Loading…

Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation

Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved stagi...

Full description

Saved in:
Bibliographic Details
Published in:Military medicine 2001-07, Vol.166 (7), p.571-576
Main Authors: BROWN, Arthur E, DOLAN, Matthew J, MALONE, John D, GARNER, Robin, BIRX, Deborah L, MICHAEL, Nelson L, ZHOU, Susan, PERFETTO, Stephen P, HAWKES, Clifton, ROBB, Merlin, LANE, James, MAYERS, Douglas, MCNEIL, John G
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503
cites
container_end_page 576
container_issue 7
container_start_page 571
container_title Military medicine
container_volume 166
creator BROWN, Arthur E
DOLAN, Matthew J
MALONE, John D
GARNER, Robin
BIRX, Deborah L
MICHAEL, Nelson L
ZHOU, Susan
PERFETTO, Stephen P
HAWKES, Clifton
ROBB, Merlin
LANE, James
MAYERS, Douglas
MCNEIL, John G
description Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts > or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count < or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets.
doi_str_mv 10.1093/milmed/166.7.571
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71032983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71032983</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503</originalsourceid><addsrcrecordid>eNpdkU9rFDEchoModq3ePUkQET3MNr_JTDLprSytLRQFqeItZDKZbspMss0fZT6LX9Ysu4h4CuF93peQB6HXQNZABD2b7TSb4QwYW_N1y-EJWoGgpGJAfzxFK0JqVjWEtyfoRYwPhEAjOniOTgAaJkq4Qr83k3VWqwnvgr93PtqI_Yh3KlnjUsS_bNpio8K0VDGpe4O3eVYO23nOzg9mtLpwesE_bcgRf7i--f4RDzYaFQ0-xxvvUrB9Tta7_WyJK8BfP19g5QZ8h6dl3m29XpLBMffRJPyYlUs2qX3jJXo2qimaV8fzFH27urzbXFe3Xz7dbC5uK01JB1UNgjHTN8QIxbty6YZGC62EMnVTdxz0yIhmDe8HPvCWGUOGkYpmBN310BJ6it4fdssXPGYTk5xt1GaalDM-R8mB0Fp0tIBv_wMffA6uvE3WwAkjINoCkQOkg48xmFHugp1VWCQQubcmD9ZksSa5LNZK5c1xN_f75G_hqKkA746AisXVGJTTNv4zzBgtzv8AM3iiKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217060195</pqid></control><display><type>article</type><title>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</title><source>Oxford Journals Online</source><creator>BROWN, Arthur E ; DOLAN, Matthew J ; MALONE, John D ; GARNER, Robin ; BIRX, Deborah L ; MICHAEL, Nelson L ; ZHOU, Susan ; PERFETTO, Stephen P ; HAWKES, Clifton ; ROBB, Merlin ; LANE, James ; MAYERS, Douglas ; MCNEIL, John G</creator><creatorcontrib>BROWN, Arthur E ; DOLAN, Matthew J ; MALONE, John D ; GARNER, Robin ; BIRX, Deborah L ; MICHAEL, Nelson L ; ZHOU, Susan ; PERFETTO, Stephen P ; HAWKES, Clifton ; ROBB, Merlin ; LANE, James ; MAYERS, Douglas ; MCNEIL, John G ; RGP160 Phase IIA Vaccine Investigators ; RGP160 Phase IIA Vaccine Investigators</creatorcontrib><description>Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts &gt; or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count &lt; or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets.</description><identifier>ISSN: 0026-4075</identifier><identifier>EISSN: 1930-613X</identifier><identifier>DOI: 10.1093/milmed/166.7.571</identifier><identifier>PMID: 11469026</identifier><identifier>CODEN: MMEDA9</identifier><language>eng</language><publisher>Bethesda, MD: Association of Military Surgeons</publisher><subject>Acquired immune deficiency syndrome ; Adult ; AIDS ; Biological and medical sciences ; Chi-Square Distribution ; Disease Progression ; Female ; HIV ; HIV Infections - immunology ; HIV-1 ; Human immunodeficiency virus ; Human viral diseases ; Humans ; Immune system ; Infections ; Infectious diseases ; Lymphocyte Count ; Lymphocytes ; Male ; Medical prognosis ; Medical sciences ; Outcome Assessment (Health Care) ; Prognosis ; Proportional Hazards Models ; RNA, Viral - blood ; Statistics, Nonparametric ; Survival Analysis ; T-Lymphocyte Subsets ; Vaccines ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>Military medicine, 2001-07, Vol.166 (7), p.571-576</ispartof><rights>2001 INIST-CNRS</rights><rights>Copyright Association of Military Surgeons of the United States Jul 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1066361$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11469026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BROWN, Arthur E</creatorcontrib><creatorcontrib>DOLAN, Matthew J</creatorcontrib><creatorcontrib>MALONE, John D</creatorcontrib><creatorcontrib>GARNER, Robin</creatorcontrib><creatorcontrib>BIRX, Deborah L</creatorcontrib><creatorcontrib>MICHAEL, Nelson L</creatorcontrib><creatorcontrib>ZHOU, Susan</creatorcontrib><creatorcontrib>PERFETTO, Stephen P</creatorcontrib><creatorcontrib>HAWKES, Clifton</creatorcontrib><creatorcontrib>ROBB, Merlin</creatorcontrib><creatorcontrib>LANE, James</creatorcontrib><creatorcontrib>MAYERS, Douglas</creatorcontrib><creatorcontrib>MCNEIL, John G</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><title>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</title><title>Military medicine</title><addtitle>Mil Med</addtitle><description>Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts &gt; or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count &lt; or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>AIDS</subject><subject>Biological and medical sciences</subject><subject>Chi-Square Distribution</subject><subject>Disease Progression</subject><subject>Female</subject><subject>HIV</subject><subject>HIV Infections - immunology</subject><subject>HIV-1</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immune system</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lymphocyte Count</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical sciences</subject><subject>Outcome Assessment (Health Care)</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>RNA, Viral - blood</subject><subject>Statistics, Nonparametric</subject><subject>Survival Analysis</subject><subject>T-Lymphocyte Subsets</subject><subject>Vaccines</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0026-4075</issn><issn>1930-613X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpdkU9rFDEchoModq3ePUkQET3MNr_JTDLprSytLRQFqeItZDKZbspMss0fZT6LX9Ysu4h4CuF93peQB6HXQNZABD2b7TSb4QwYW_N1y-EJWoGgpGJAfzxFK0JqVjWEtyfoRYwPhEAjOniOTgAaJkq4Qr83k3VWqwnvgr93PtqI_Yh3KlnjUsS_bNpio8K0VDGpe4O3eVYO23nOzg9mtLpwesE_bcgRf7i--f4RDzYaFQ0-xxvvUrB9Tta7_WyJK8BfP19g5QZ8h6dl3m29XpLBMffRJPyYlUs2qX3jJXo2qimaV8fzFH27urzbXFe3Xz7dbC5uK01JB1UNgjHTN8QIxbty6YZGC62EMnVTdxz0yIhmDe8HPvCWGUOGkYpmBN310BJ6it4fdssXPGYTk5xt1GaalDM-R8mB0Fp0tIBv_wMffA6uvE3WwAkjINoCkQOkg48xmFHugp1VWCQQubcmD9ZksSa5LNZK5c1xN_f75G_hqKkA746AisXVGJTTNv4zzBgtzv8AM3iiKQ</recordid><startdate>200107</startdate><enddate>200107</enddate><creator>BROWN, Arthur E</creator><creator>DOLAN, Matthew J</creator><creator>MALONE, John D</creator><creator>GARNER, Robin</creator><creator>BIRX, Deborah L</creator><creator>MICHAEL, Nelson L</creator><creator>ZHOU, Susan</creator><creator>PERFETTO, Stephen P</creator><creator>HAWKES, Clifton</creator><creator>ROBB, Merlin</creator><creator>LANE, James</creator><creator>MAYERS, Douglas</creator><creator>MCNEIL, John G</creator><general>Association of Military Surgeons</general><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88F</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M1Q</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>200107</creationdate><title>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</title><author>BROWN, Arthur E ; DOLAN, Matthew J ; MALONE, John D ; GARNER, Robin ; BIRX, Deborah L ; MICHAEL, Nelson L ; ZHOU, Susan ; PERFETTO, Stephen P ; HAWKES, Clifton ; ROBB, Merlin ; LANE, James ; MAYERS, Douglas ; MCNEIL, John G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>AIDS</topic><topic>Biological and medical sciences</topic><topic>Chi-Square Distribution</topic><topic>Disease Progression</topic><topic>Female</topic><topic>HIV</topic><topic>HIV Infections - immunology</topic><topic>HIV-1</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immune system</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lymphocyte Count</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical sciences</topic><topic>Outcome Assessment (Health Care)</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>RNA, Viral - blood</topic><topic>Statistics, Nonparametric</topic><topic>Survival Analysis</topic><topic>T-Lymphocyte Subsets</topic><topic>Vaccines</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BROWN, Arthur E</creatorcontrib><creatorcontrib>DOLAN, Matthew J</creatorcontrib><creatorcontrib>MALONE, John D</creatorcontrib><creatorcontrib>GARNER, Robin</creatorcontrib><creatorcontrib>BIRX, Deborah L</creatorcontrib><creatorcontrib>MICHAEL, Nelson L</creatorcontrib><creatorcontrib>ZHOU, Susan</creatorcontrib><creatorcontrib>PERFETTO, Stephen P</creatorcontrib><creatorcontrib>HAWKES, Clifton</creatorcontrib><creatorcontrib>ROBB, Merlin</creatorcontrib><creatorcontrib>LANE, James</creatorcontrib><creatorcontrib>MAYERS, Douglas</creatorcontrib><creatorcontrib>MCNEIL, John G</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><creatorcontrib>RGP160 Phase IIA Vaccine Investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Military Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Military Database</collection><collection>Psychology Database</collection><collection>ProQuest Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Military medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BROWN, Arthur E</au><au>DOLAN, Matthew J</au><au>MALONE, John D</au><au>GARNER, Robin</au><au>BIRX, Deborah L</au><au>MICHAEL, Nelson L</au><au>ZHOU, Susan</au><au>PERFETTO, Stephen P</au><au>HAWKES, Clifton</au><au>ROBB, Merlin</au><au>LANE, James</au><au>MAYERS, Douglas</au><au>MCNEIL, John G</au><aucorp>RGP160 Phase IIA Vaccine Investigators</aucorp><aucorp>RGP160 Phase IIA Vaccine Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation</atitle><jtitle>Military medicine</jtitle><addtitle>Mil Med</addtitle><date>2001-07</date><risdate>2001</risdate><volume>166</volume><issue>7</issue><spage>571</spage><epage>576</epage><pages>571-576</pages><issn>0026-4075</issn><eissn>1930-613X</eissn><coden>MMEDA9</coden><abstract>Systems for the staging of individuals with human immunodeficiency virus type 1 (HIV-1) infection were developed 15 years ago. Subsequently, assays for quantitating HIV-1 RNA and immunophenotyping of lymphocyte subsets have been developed and validated. The utility of these assays for improved staging in early disease was evaluated in 256 HIV-infected adults (52% minority) with CD4 counts &gt; or = 400 cells/microL followed in U.S. military medical centers before the highly active anti-retroviral therapy era. HIV viral load (RNA) was quantitated; the frequencies of select CD4+ immunophenotypes were determined in 112 subjects. The results were analyzed in relation to three outcome measures: death, first acquired immunodeficiency syndrome-defining opportunistic infection, and CD4 count &lt; or = 200 cells/microL. Serum RNA level and CD4 count were each found to be predictive of all three outcomes. In addition, increases in the T-cell subsets CD28-CD4+ and CD29+CD26-CD4+ were found to be independently predictive of more rapid progression. The classification of early-stage HIV patients is improved by the quantitation of both viral RNA and T-lymphocyte subsets.</abstract><cop>Bethesda, MD</cop><pub>Association of Military Surgeons</pub><pmid>11469026</pmid><doi>10.1093/milmed/166.7.571</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0026-4075
ispartof Military medicine, 2001-07, Vol.166 (7), p.571-576
issn 0026-4075
1930-613X
language eng
recordid cdi_proquest_miscellaneous_71032983
source Oxford Journals Online
subjects Acquired immune deficiency syndrome
Adult
AIDS
Biological and medical sciences
Chi-Square Distribution
Disease Progression
Female
HIV
HIV Infections - immunology
HIV-1
Human immunodeficiency virus
Human viral diseases
Humans
Immune system
Infections
Infectious diseases
Lymphocyte Count
Lymphocytes
Male
Medical prognosis
Medical sciences
Outcome Assessment (Health Care)
Prognosis
Proportional Hazards Models
RNA, Viral - blood
Statistics, Nonparametric
Survival Analysis
T-Lymphocyte Subsets
Vaccines
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
title Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease : Contribution of HIV-1 RNA and T lymphocyte subset quantitation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20prognosis%20of%20patients%20with%20early-stage%20human%20immunodeficiency%20virus%20(HIV)%20disease%20:%20Contribution%20of%20HIV-1%20RNA%20and%20T%20lymphocyte%20subset%20quantitation&rft.jtitle=Military%20medicine&rft.au=BROWN,%20Arthur%20E&rft.aucorp=RGP160%20Phase%20IIA%20Vaccine%20Investigators&rft.date=2001-07&rft.volume=166&rft.issue=7&rft.spage=571&rft.epage=576&rft.pages=571-576&rft.issn=0026-4075&rft.eissn=1930-613X&rft.coden=MMEDA9&rft_id=info:doi/10.1093/milmed/166.7.571&rft_dat=%3Cproquest_cross%3E71032983%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3081-21966eb40e9a781968d4c9ca9ae242871cf60c647bd7d756ee0df394f1c8b1503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217060195&rft_id=info:pmid/11469026&rfr_iscdi=true